Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00227890 · ClinicalTrials.gov registry record · Phase 2
Skills and Motivation at the Rhode Island Training School (Project SMART) - 1
A Phase 2 study of Alcoholic, Marijuana Misuse, sponsored by University of Rhode Island.
- Completed
- Registry status
- Phase 2
- Development phase
- 205
- Enrollment target
- 2
- Study locations
NCT00227890: Completed Phase 2 study of Alcoholic, Marijuana Misuse, sponsored by University of Rhode Island.
NCT00227890 is a Phase 2 study of Alcoholic, Marijuana Misuse that has completed, run by University of Rhode Island. The registered enrollment target is 205 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (54% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00227890, a Phase 2 study of Alcoholic, Marijuana Misuse, has completed, sponsored by University of Rhode Island.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 205 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will focus on treating substance abusing incarcerated teens using individually administered Motivational Interviewing (MI) followed by group Cognitive Behavior Therapy (CBT). The control group receives individualized Relaxation Training (RT) followed by group Treatment as Usual (TU). Currently, there is little research regarding effective group treatments for incarcerated teens and this study will address this gap in our knowledge base. We seek to reduce substance use and associated risky behaviors post-release (including driving under the influence, risky sexual behaviors, etc.).
Conditions Studied
Interventions
- BEHAVIORAL MI/CBT
- BEHAVIORAL RT/TU
Study Locations (2)
Rhode Island
- Rhode Island Training School - Cranston
- University of Rhode Island, Social Sciences Research Center - Kingston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2005-03 |
| Est. Completion | 2011-09 |
| Phase | Phase 2 |
What the finished NCT00227890 record still lists
NCT00227890 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (54% higher).
The record links to 1 condition, with Alcoholic, Marijuana Misuse appearing as the primary indexed condition, and to 2 interventions - of which MI/CBT is the first listed.
NCT00227890 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00227890 about?
NCT00227890 is a clinical study titled "Skills and Motivation at the Rhode Island Training School (Project SMART) - 1". This study will focus on treating substance abusing incarcerated teens using individually administered Motivational Interviewing (MI) followed by group Cognitive Behavior Therapy (CBT). The control group receives individualized Relaxation Training (RT) followed by group Treatment as Usual (TU). Curr...
What is the current status of trial NCT00227890?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 205 participants. The study started on 2005-03. Estimated completion is 2011-09.
What conditions does trial NCT00227890 study?
This clinical trial studies the following conditions: Alcoholic, Marijuana Misuse.
What interventions are being tested in trial NCT00227890?
The interventions under investigation include: MI/CBT (BEHAVIORAL), RT/TU (BEHAVIORAL).
Who is sponsoring clinical trial NCT00227890?
This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00227890 being conducted?
This trial has 2 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00227890's enrollment target sits among peer trials
205 298th of 2000 higher than 1,702 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia